DisCoVisc Comparative Evaluation

Completed · Phase 3

Conditions studied: Cataracts

In brief

A comparison of the ability of DisCoVisc to that of other Opthalmic Viscosurgical Devices (OVDs) (DuoVisc®, BioVisc®, Healon5®, or Amvisc PLUS) regarding endothelial protection and anterior chamber space maintenance during non-eventful cataract surgery.

Key facts

Study ID

NCT00732225

Run by

Alcon Research

People needed

173

Starts

2007-05-01

Last updated by the study team

2010-07-30

Who can join

Age: 49 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Unilateral operable cataracts

You may not qualify if…

• Preoperative Endothelial Cell Count (ECC) ≤1500 cells/mm2
• Intraocular Pressure (IOP) > 21
• History of ocular inflammation
• Systemic or ocular diseases affecting corneal endothelium

Where it is running

• Alcon Call Center for Trial Locations — Fort Worth, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.